Form 8-K - Current report:
SEC Accession No. 0001140361-25-006756
Filing Date
2025-03-03
Accepted
2025-03-03 16:18:38
Documents
13
Period of Report
2025-02-25
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20044803_8k.htm   iXBRL 8-K 26074
  Complete submission text file 0001140361-25-006756.txt   159766

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA bcpc-20250225.xsd EX-101.SCH 3979
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcpc-20250225_lab.xml EX-101.LAB 21966
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcpc-20250225_pre.xml EX-101.PRE 16042
15 EXTRACTED XBRL INSTANCE DOCUMENT ef20044803_8k_htm.xml XML 4064
Mailing Address 5 PARAGON DRIVE MONTVALE NJ 07645
Business Address 5 PARAGON DRIVE MONTVALE NJ 07645 (845) 326-5600
BALCHEM CORP (Filer) CIK: 0000009326 (see all company filings)

EIN.: 132578432 | State of Incorp.: MD | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-13648 | Film No.: 25698217
SIC: 2800 Chemicals & Allied Products
(CF Office: 08 Industrial Applications and Services)